Institute of Medicine (U.S.). Board on Population Health and Public Health Practice, Institute of Medicine (U.S.). Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process, ebrary, Inc, & Wizemann, T. M. (2011). Public health effectiveness of the FDA 510(k) clearance process: Balancing patient safety and innovation : workshop report. National Academies Press.
Uspješno je kopirano u međuspremnik
Kopiranje u međuspremnik neuspjelo
Čikaški stil citiranja (17. izdanje)
Institute of Medicine (U.S.). Board on Population Health and Public Health Practice, Institute of Medicine (U.S.). Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process, Inc ebrary, i Theresa M. Wizemann. Public Health Effectiveness of the FDA 510(k) Clearance Process: Balancing Patient Safety and Innovation : Workshop Report. Washington, D.C.: National Academies Press, 2011.
Uspješno je kopirano u međuspremnik
Kopiranje u međuspremnik neuspjelo
MLA način citiranja (9. izdanje)
Institute of Medicine (U.S.). Board on Population Health and Public Health Practice, et al. Public Health Effectiveness of the FDA 510(k) Clearance Process: Balancing Patient Safety and Innovation : Workshop Report. National Academies Press, 2011.
Uspješno je kopirano u međuspremnik
Kopiranje u međuspremnik neuspjelo
Upozorenje: Ovi citati možda nisu uvijek 100% točni.